Literature DB >> 32935386

Organ utilization - the next hurdle in transplantation?

James Neuberger1, Chris Callaghan2.   

Abstract

Nonutilization of organs from consented deceased donors remains a significant factor in limiting patient access to transplantation. Critical to reducing waste is a clear understanding of why organs are not used: accurate metrics are essential to identify the extent and causes of waste but use of these measures as targets or comparators between units/jurisdictions must be done with caution as focus on any one measure may result in unintended adverse consequences. Comparison between centres or countries may be misleading because of variation in definitions, patient or graft characteristics. Two of the most challenging areas to improve appropriate deceased donor organ utilization are appetite for risk and lack of validated tools to help identify an organ that will function appropriately. Currently, the implanting surgeon is widely considered to be accountable for the use of a donated organ so guidelines must be clear to allow and support sensible decisions and recognition that graft failure or inadvertent disease transmission are not necessarily attributable to poor decision-making. Accepting an organ involves balancing risk and benefit for the potential recipient. Novel technologies such as machine perfusion may allow for more robust guidance as to the functioning of the organ.
© 2020 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  donation; transplantation; utilisation

Mesh:

Year:  2020        PMID: 32935386     DOI: 10.1111/tri.13744

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

1.  Hyperspectral Imaging as a Tool for Viability Assessment During Normothermic Machine Perfusion of Human Livers: A Proof of Concept Pilot Study.

Authors:  Margot Fodor; Lukas Lanser; Julia Hofmann; Giorgi Otarashvili; Marlene Pühringer; Benno Cardini; Rupert Oberhuber; Thomas Resch; Annemarie Weissenbacher; Manuel Maglione; Christian Margreiter; Philipp Zelger; Johannes D Pallua; Dietmar Öfner; Robert Sucher; Theresa Hautz; Stefan Schneeberger
Journal:  Transpl Int       Date:  2022-05-16       Impact factor: 3.842

Review 2.  3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications.

Authors:  Earnest P Chen; Zeren Toksoy; Bruce A Davis; John P Geibel
Journal:  Front Bioeng Biotechnol       Date:  2021-05-13

3.  Risk Aversion, Organ Utilization and Changing Behavior.

Authors:  Adnan Sharif
Journal:  Transpl Int       Date:  2022-04-07       Impact factor: 3.842

4.  Consent in organ transplantation: putting legal obligations and guidelines into practice.

Authors:  Farrah Raza; James Neuberger
Journal:  BMC Med Ethics       Date:  2022-07-05       Impact factor: 2.834

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.